Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer

by Jochen H Lorch
Published 2009-11-01

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma

by Glenn J. Hanna, Alec J. Kacew, Anusha R. Tanguturi, Hans J. Grote, Victoria Vergara, Beatrice Brunkhorst, Guilherme Rabinowits, Manisha Thakuria, Nicole R. LeBoeuf, Christian Ihling, James A. DeCaprio, Jochen H. Lorch
Published 2020-06-01

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

by Howard L. Kaufman, Jeffery S. Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden, Sandra P. D’Angelo, Kent C. Shih, Céleste Lebbé, Michele Milella, Isaac Brownell, Karl D. Lewis, Jochen H. Lorch, Anja von Heydebreck, Meliessa Hennessy, Paul Nghiem
Published 2018-01-01